Farmacy

Aug 25 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #gw #pharma

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Aug 24 2017

Contacts – Daiichi Sankyo #pharma #ad #agencies

#sankyo pharma inc # Contacts Please refer to Handling of personal information on this website and Terms and Conditions before you make an inquiry. Depending on the nature of your inquiry, it may take some time to reply or we may answer your inquiries by phone. Also, depending on the inquiry, Daiichi Sankyo’s affiliate may reply to your question. If this is the case, please note that we share the personal information you entered in our site with the affiliate. The answers Daiichi Sankyo provides to its customers are intended only for the person to whom it is addressed. Please …

Aug 13 2017

Daiichi Sankyo – Benicar Manufacturer, History, Products #millenium #pharma

#sankyo pharma inc # Daiichi Sankyo Daiichi Sankyo is a global pharmaceutical holding company and the second largest drug company in Japan. It faces lawsuits over its blood pressure drug Benicar, which can cause serious gastrointestinal side effects. Daiichi Sankyo (Die-EE-chee SANK-yo) Company, Limited, makes pharmaceuticals for use by humans and animals and manufactures medical tools and equipment. It also produces food, food additives, livestock feeds and agrochemicals and researches and promotes products through related companies throughout the world. Its top-selling hypertensive drug, Benicar (olmesartan medoxomil), brought in $3.1 billion in worldwide sales in the 2013 fiscal year and $2.4 …

Aug 7 2017

Daiichi Sankyo – Benicar Manufacturer, History, Products #pharmaceutical #packaging #companies

#sankyo pharma inc # Daiichi Sankyo Daiichi Sankyo is a global pharmaceutical holding company and the second largest drug company in Japan. It faces lawsuits over its blood pressure drug Benicar, which can cause serious gastrointestinal side effects. Daiichi Sankyo (Die-EE-chee SANK-yo) Company, Limited, makes pharmaceuticals for use by humans and animals and manufactures medical tools and equipment. It also produces food, food additives, livestock feeds and agrochemicals and researches and promotes products through related companies throughout the world. Its top-selling hypertensive drug, Benicar (olmesartan medoxomil), brought in $3.1 billion in worldwide sales in the 2013 fiscal year and $2.4 …

Jul 31 2017

Who We Are – About Us – Daiichi Sankyo #jrs #pharma

#sankyo pharma inc # Who We Are Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 16,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients …

Jul 22 2017

Contacts – Daiichi Sankyo #merk #pharma

#sankyo pharma inc # Contacts Please refer to Handling of personal information on this website and Terms and Conditions before you make an inquiry. Depending on the nature of your inquiry, it may take some time to reply or we may answer your inquiries by phone. Also, depending on the inquiry, Daiichi Sankyo’s affiliate may reply to your question. If this is the case, please note that we share the personal information you entered in our site with the affiliate. The answers Daiichi Sankyo provides to its customers are intended only for the person to whom it is addressed. Please …

Jul 22 2017

Daiichi Sankyo – Benicar Manufacturer, History, Products #pharma #manufacturers

#sankyo pharma inc # Daiichi Sankyo Daiichi Sankyo is a global pharmaceutical holding company and the second largest drug company in Japan. It faces lawsuits over its blood pressure drug Benicar, which can cause serious gastrointestinal side effects. Daiichi Sankyo (Die-EE-chee SANK-yo) Company, Limited, makes pharmaceuticals for use by humans and animals and manufactures medical tools and equipment. It also produces food, food additives, livestock feeds and agrochemicals and researches and promotes products through related companies throughout the world. Its top-selling hypertensive drug, Benicar (olmesartan medoxomil), brought in $3.1 billion in worldwide sales in the 2013 fiscal year and $2.4 …

Jul 8 2017

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ #kv #pharma

#sankyo pharma # UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ Times have been tough for Daiichi Sankyo, and they’re about to get tougher for some of the Japanese company’s U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, with more layoffs expected in mid-April. The cutbacks are part of a revamp at Daiichi’s U.S. business, based in Parsippany, NJ. The reasons for cutbacks are clear: Daiichi’s exclusivity on the cholesterol drug Welchol expires in June, and a bigger product–the blood pressure drug Benicar–loses its lock on the market next year. That …

Jul 8 2017

Who We Are – About Us – Daiichi Sankyo #watson #pharma

#sankyo pharma inc # Who We Are Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 16,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients …

Jul 8 2017

Contacts – Daiichi Sankyo #healthcare #market #research

#sankyo pharma inc # Contacts Please refer to Handling of personal information on this website and Terms and Conditions before you make an inquiry. Depending on the nature of your inquiry, it may take some time to reply or we may answer your inquiries by phone. Also, depending on the inquiry, Daiichi Sankyo’s affiliate may reply to your question. If this is the case, please note that we share the personal information you entered in our site with the affiliate. The answers Daiichi Sankyo provides to its customers are intended only for the person to whom it is addressed. Please …